Upholding Foundations While Pioneering Progress: Steady Reform for Sustainable Development
Upholding Foundations While Pioneering Progress: Steady Reform for Sustainable Development
On January 23, 2025, a special scheduling meeting for the performance evaluation of public hospitals across the province was held by the Gansu Provincial Health Commission. The meeting announced outstanding news: Gansu Wuwei Cancer Hospital was ranked in the top tier alongside large affiliated hospitals of Lanzhou University and provincial-level Class III Grade A hospitals in the latest national performance evaluation of tertiary public hospitals. It claimed the top spot among specialized hospitals in the province and secured first place among all hospitals in the Hexi Corridor region, setting a new record for Wuwei medical institutions in national evaluations. The National Performance Evaluation of Tertiary Public Hospitals (a comprehensive assessment of medical quality and hospital management standards) is a key initiative by the CPC Central Committee and the State Council to promote high-quality development in public hospitals. Regarded as the "gold standard" by the National Health Commission for evaluating the comprehensive medical capabilities and standards of tertiary hospitals nationwide, this annual assessment covers four major dimensions—medical quality, operational efficiency, sustainable development, and patient satisfaction—along with 56 specific indicators, including patient data, technical proficiency, and management competence. It represents the most authoritative and official hospital ranking system in China.
After nearly 50 years of remarkable transformation, Gansu Wuwei Cancer Hospital became the first Class III Grade A hospital in the Jinchang-Wuwei region a decade ago when it passed the rigorous evaluation by China's National Health Commission. The hospital has not only put into operation China's first heavy ion therapy system but also manages the second domestic heavy ion treatment system at Lanzhou Heavy Ion Center. To date, the hospital has completed nearly 1,800 heavy ion therapy cases, bringing new hope to cancer patients while setting new benchmarks in oncology treatment.
Optimizing Disciplinary Structure to Enhance Institutional Prestige
In terms of discipline development, the hospital has intensified its efforts in specialty cultivation, establishing three flagship clinical systems focusing on oncology, digestive diseases, and cardiovascular diseases. It has built five provincial-level key disciplines: Oncology, Gastroenterology, Radiotherapy, Gastrointestinal Surgery, and Respiratory & Critical Care Medicine. Additionally, thirteen municipal-level key disciplines have been developed, including Cardiology, Hematology, Neurology, Thoracic Surgery, and Oncology Specialty Clusters. The Radiotherapy Department has entered a three-year construction cycle as a national clinical key specialty, while the Oncology Department passed on-site evaluation for provincial clinical key discipline status. The hospital has received national certifications as a Stroke Center, Chest Pain Center, and Trauma Center. These achievements have solidified its distinctive disciplinary features and technological advantages in cancer prevention/treatment and heavy ion therapy.
Precision Medical Innovation: Advancing Cutting-Edge Technologies
In terms of technological innovation, the hospital has pioneered multiple groundbreaking global firsts, including:
• High-frequency oscillatory breathing control technology for precision heavy ion therapy
• Bladder volume precision management technology for bladder cancer treatment
• Single-session heavy ion therapy with surgically implanted spacers between organs and tumors
• "Heavy Ion Surgical Technology" with organ motion control (enabling single-treatment completion)
• Transcecal appendectomy using NOSES (Natural Orifice Specimen Extraction Surgery)
• Robotic-assisted rectal cancer radical surgery via NOSES
• Endoscopic ultrasound intervention and NOTES (Natural Orifice Transluminal Endoscopic Surgery)
• 3D printing reconstruction procedures
• Autologous hematopoietic stem cell transplantation
• Allogeneic hematopoietic stem cell transplantation
Transappendiceal appendectomy NOSES procedure
Surgical Robotic Rectal Cancer Radical NOSES Surgery
Gathering of National Elite Talents: Building an International Workforce
In talent cultivation, the hospital has appointed Professor Wang Junjie, Chairman of the Chinese Medical Association's Radiation Oncology Therapy Committee, as Dean of its Lanzhou campus. It has established 50 national expert workstations, including those of Professor Shen Wenjiang, Lifetime Honorary Professor of Peking University Health Science Center's Department of Radiation Oncology, and Professor Xu Bo, Standing Committee Member of the Chinese Medical Association's Tumor Radiotherapy Branch. The hospital has also recruited over 80 renowned domestic and international experts for long-term residency, including distinguished Taiwanese radiation physicist Jia-Ming Wu and radiation oncologist Professor Yee-Min Jen.
Precision Medical Technology: Safeguarding the Future of Healthcare
The hospital is equipped with advanced medical systems including: China's first and second heavy ion therapy systems, The domestically developed Toumai four-arm surgical robot (the first of its kind in China), Discovery 710 PET-CT scanner, Siemens Skyra 3.0T supersonic MRI, Siemens dual-source photon CT, Siemens Artis pheno angiography system, Varian Vital Beam linear accelerator, Elekta Infinity "visualized" 4D image-guided linear accelerator. This comprehensive array of cutting-edge equipment fully meets the requirements for precision diagnosis and treatment.
Iterative upgrading of treatment pods
The domestically developed Toumai four-arm surgical robot (the first of its kind in China)
Super-iterative PET-CT
VitalBeam Linear Accelerator
Elekta Infinity 4D Image-Guided Linear Accelerator
3.0T Supersonic High-end Radiotherapy Positioning MRI
Establishing Gold-Standard Guidelines: Charting the Course for Global Healthcare
The hospital has compiled several groundbreaking monographs, including "Standard Operating Procedures for Carbon Ion Radiotherapy", "Regulations for Radiation Safety Management and Equipment Operation in Carbon Ion Therapy", "Precision Carbon Ion Radiotherapy Series: Technical Volume" (covering clinical, physics and technical aspects), and "Comprehensive Perspectives on Carbon Ion Therapy for Cancer", all of which represent world-first publications in this field.
Heavy Ion Meets Wellness: Charting New Paths for Medicine
The hospital has collaborated with the Institute of Modern Physics, Chinese Academy of Sciences and Wuwei Boruiling Medical Equipment Co., Ltd. to successfully develop and produce Wuwei City's and even Gansu Province's first fully intelligent medical devices, including a bladder volume measuring instrument and a 360-degree radiotherapy chair. They have also transformed local specialty products into high-value-added healthcare items such as the "Tranquil Nature" desertistanche deserticola tea and the "Herbal Wellness Tea" that combines medicinal and edible properties. It is reported that by 2025, medical devices including a diaphragmatic pacemaker, a positron detection and localization device (PET-CT detector), an automated hydroxybenzenealanine urine detector, an infusion management system, and a cost-control management system will be successively put into production. These achievements have established new benchmarks for Wuwei City in the global medical equipment field.
Bladder Volume Monitor
Production Launch: June 18, 2024
360° Seated Radiotherapy Chair Makes Debut at Sci-Tech Exhibition Hall on January 26, 2025
The Desert Cistanche Health Tea entered production on January 1, 2025
"Steady Progress and Principled Innovation", the outstanding achievements affirm the integrated excellence in medical quality and management at Wuwei Cancer Hospital, while also serving as both inspiration and impetus for future development. Moving forward, we will remain steadfast in our service philosophy of "Undivided Dedication to Healing", continuing to deepen reform and innovation. We are committed to elevating medical service quality and standards, making greater contributions to safeguarding public health and advancing regional healthcare development, while writing new chapters of excellence in the medical field.